Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
- 10 August 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 100 (6), 587-593
- https://doi.org/10.1161/01.cir.100.6.587
Abstract
Background—We prospectively investigated lepirudin for further parenteral anticoagulation in patients with heparin-induced thrombocytopenia (HIT). Methods and Results—Patients with confirmed HIT (n...Keywords
This publication has 16 references indexed in Scilit:
- Heparin-induced Thrombocytopenia: Towards ConsensusThrombosis and Haemostasis, 1998
- DanaparoidDrugs, 1997
- Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institutionAmerican Journal of Hematology, 1997
- A 14-year study of heparin-induced thrombocytopeniaAmerican Journal Of Medicine, 1996
- Description of an In Vitro Platelet Function Analyzer-PFA-100™Seminars in Thrombosis and Hemostasis, 1995
- Hirudins: Antithrombin AnticoagulantsAnnals of Pharmacotherapy, 1992
- Diagnostic and therapeutic strategies of white clot syndromeThe American Journal of Surgery, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.JCI Insight, 1990
- Heparin-Induced ThrombocytopeniaAnnual Review of Medicine, 1989
- Heparin-Associated ThrombocytopeniaAnnals of Internal Medicine, 1984